BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetics of ceftazidime in elderly patients. 1989

M D Higbee, and E Swenson, and W M Gooch
Department of Pediatrics, School of Medicine, University of Utah, Salt Lake City.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D002442 Ceftazidime Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients. Ceftazidime Anhydrous,Ceftazidime Pentahydrate,Fortaz,Fortum,GR-20263,LY-139381,Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-,Tazidime,GR 20263,GR20263,LY 139381,LY139381
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

M D Higbee, and E Swenson, and W M Gooch
Pharmacokinetics of ceftazidime in acutely ill hospitalised elderly patients.
January 1992, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
M D Higbee, and E Swenson, and W M Gooch
Pharmacokinetics of ceftazidime in elderly patients and young volunteers.
January 1984, Scandinavian journal of infectious diseases,
M D Higbee, and E Swenson, and W M Gooch
Pharmacokinetics of ceftazidime in elderly volunteers.
November 1985, Antimicrobial agents and chemotherapy,
M D Higbee, and E Swenson, and W M Gooch
Population pharmacokinetics of ceftazidime in burn patients.
December 2003, British journal of clinical pharmacology,
M D Higbee, and E Swenson, and W M Gooch
Pharmacokinetics of ceftazidime in febrile neutropenic patients.
January 2001, Scandinavian journal of infectious diseases,
M D Higbee, and E Swenson, and W M Gooch
Multiple-dose pharmacokinetics of ceftazidime in cancer patients.
August 1983, Antimicrobial agents and chemotherapy,
M D Higbee, and E Swenson, and W M Gooch
Pharmacokinetics of ceftazidime in patients with renal insufficiency.
February 1984, Antimicrobial agents and chemotherapy,
M D Higbee, and E Swenson, and W M Gooch
[The pharmacokinetics of ceftazidime in the burned patients].
September 1994, Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns,
M D Higbee, and E Swenson, and W M Gooch
Altered pharmacokinetics of ceftazidime in critically ill patients.
July 1999, Antimicrobial agents and chemotherapy,
M D Higbee, and E Swenson, and W M Gooch
Pharmacokinetics of ceftazidime in patients undergoing peritoneal dialysis.
July 1983, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!